Rectal cancer chemoradiotherapy was tied to an increased risk for second nonpelvic cancers but not second pelvic cancers.

A stunning clinical trial has delivered results that doctors rarely see. Every single patient in the study saw their rectal ...

A recent meta-analysis reveals no link between pathologic complete response and long-term survival in rectal cancer, ...

Pathologic complete response does not predict overall or disease-free survival in patients with rectal cancer, according to a ...

The American Cancer Society says an uptick in colon cancer cases in the 45-49 age group is a result of lowered screening ages ...

The FDA approved an investigational new drug application for ABT-301, clearing the way for a new clinical trial in metastatic ...

Patients with secondary rectal cancer after radiotherapy for prostate cancer have shorter survival compared with matched treatment-naïve patients. However, a new study by investigators at MSK has ...

This therapy “unmasks” tumor cells, making it easier for the patient’s own immune system to recognize and kill cancer cells. 5-10% of rectal tumors are believed to be MMRd 2-10% of other types of ...

Reply to: Neoadjuvant Therapy for Locally Advanced Rectal Cancer: Omission of Radiotherapy or Not? The following represents disclosure information provided by authors of this manuscript. All ...